Yahoo
NasdaqGM - Nasdaq Real Time Price USD

LifeMD, Inc. (LFMD)

2.3700 +0.0800 (+3.49%)
At close: November 6 at 4:00:01 PM EST
2.3782 +0.0082 (+0.35%)
After hours: November 6 at 5:25:22 PM EST
Trade LifeMD on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
191,592.4580
194,055.1980
154,824.0750
152,547.0060
119,033.5200
Cost of Revenue
23,949.4660
27,714.8080
21,440.7990
18,900.4640
18,668.0280
Gross Profit
167,642.9920
166,340.3900
133,383.2760
133,646.5420
100,365.4920
Operating Expense
187,842.7560
174,010.0840
153,785.2640
148,135.8150
140,051.6770
Operating Income
-20,199.7640
-7,669.6940
-20,401.9880
-14,489.2730
-39,686.1850
Net Non Operating Interest Income Expense
-134.4060
-1,360.9670
-2,175.4050
-2,596.5860
-1,275.9460
Other Income Expense
--
-1,155.8510
--
-325.1980
-3,698.1960
Pretax Income
-21,490.0210
-10,186.5120
-22,577.3930
-17,411.0570
-44,660.3270
Tax Provision
45.7210
45.7210
598
428
360.7000
Net Income Common Stockholders
-2,905.2390
11,247.8560
-24,515.2660
-23,702.2420
-48,641.9090
Diluted NI Available to Com Stockholders
-2,905.2390
11,247.8560
-24,515.2660
-23,702.2420
-48,641.9090
Basic EPS
-0.04
0.25
-0.53
-0.70
-1.57
Diluted EPS
-0.04
0.25
-0.53
-0.70
-1.57
Basic Average Shares
47,025.2300
45,129.6170
41,196.2920
33,905.1550
30,976.4550
Diluted Average Shares
47,025.2300
45,129.6170
41,196.2920
33,905.1550
30,976.4550
Total Operating Income as Reported
-20,199.7640
-7,669.6940
-20,401.9880
-14,489.2730
-43,447.7810
Total Expenses
211,792.2220
201,724.8920
175,226.0630
167,036.2790
158,719.7050
Net Income from Continuing & Discontinued Operation
201.0110
14,354.1060
-21,409.0160
-20,595.9920
-45,535.6590
Normalized Income
-21,070.9964
-10,637.6181
-23,724.2680
-20,354.5975
-42,791.9674
Interest Expense
134.4060
1,360.9670
2,175.4050
--
--
Net Interest Income
-134.4060
-1,360.9670
-2,175.4050
-2,596.5860
-1,275.9460
EBIT
-21,355.6150
-8,825.5450
-20,401.9880
-14,489.2730
-39,686.1850
EBITDA
-13,489.2990
-1,517.0870
-14,212.6260
-7,889.0470
-35,915.9510
Reconciled Cost of Revenue
23,949.4660
27,714.8080
21,440.7990
18,900.4640
18,668.0280
Reconciled Depreciation
7,866.3160
7,308.4580
6,189.3620
6,600.2260
3,770.2340
Net Income from Continuing Operation Net Minority Interest
-21,764.5070
-11,497.9180
-23,724.2680
-20,595.9920
-45,535.6590
Total Unusual Items Excluding Goodwill
-1,155.8510
-1,155.8510
0
-325.1980
-3,698.1960
Total Unusual Items
-1,155.8510
-1,155.8510
0
-325.1980
-3,698.1960
Normalized EBITDA
-12,333.4480
-361.2360
-14,212.6260
-7,563.8490
-32,217.7550
Tax Rate for Calcs
0.0004
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-462.3404
-295.5511
0
-83.8035
-954.5044
12/31/2022 - 1/29/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: